Please provide your email address to receive an email when new articles are posted on . Cardiogenic shock is a strong independent predictor of in-hospital mortality in children with acute ...

Please provide your email address to receive an email when new articles are posted on . Delayed ECMO initiation was tied to increased in-hospital mortality among patients with cardiogenic shock. ECMO ...

Nursing staff interventions regarding shock team activation significantly improved the time of diagnosis and acceptance of patients with cardiogenic shock. A cardiovascular specialty hospital in north ...

The “uneven playing field” related to demographics could be smoothed by stroke networks and standardized care.

Windtree Therapeutics, Inc. announced that it is preparing for an interim analysis of its SEISMiC C Phase 2 study of istaroxime, targeting results for July 2025. This global, placebo-controlled, ...

Johnson & Johnson MedTech today announced new data confirming the benefits of its Abiomed business' Impella CP system.

ATLANTA -- Routine use of the Impella CP microaxial flow pump significantly improved survival in patients with infarct-related cardiogenic shock, the randomized DanGer Shock trial showed. In more than ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. ST. LOUIS – Cardiogenic shock is a serious ...

In a recent study published in Scientific Reports, researchers from Korea explored the association between prolonged exposure to air pollution (AP) and ST-elevation myocardial infarction (STEMI) and ...

A Japanese registry study reveals how DanGer shock criteria predict survival in heart attack patients treated with Impella.

SANTA CLARA, Calif.--(BUSINESS WIRE)--PercAssist, Inc., a medical device company developing innovative technology for extravascular / extracardiac Mechanical Circulatory Support to provide hemodynamic ...